在卵巢癌中,EZH2抑制通过重编程异染色体循环DNA动力学来恢复瘤抑制剂SFRP1的活动
Tao Han1,2, Qingya Yan1,2, Yaqi Zhang1,2
1The Third Affiliated Hospital of Henan Medical University, Institutes of Health Central Plains, Henan Medical University, Xinxiang 453003, China.
在卵巢癌中,EZH2抑制重新编程了异染色体循环DNA (eccDNA) 动态,可能恢复瘤抑制剂SFRP1的表达. 这揭示了一个新的表观遗传-eccDNA轴,影响癌症的进展和治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 外染色体循环DNA (eccDNA) 驱动癌症进展,瘤基因放大和瘤异质性.
- 在癌症中,eccDNA和像EZH2这样的表观遗传调节器之间的相互作用是不太了解的.
研究的目的:
- 研究EZH2抑制剂Tazemetostat对卵巢癌中eccDNA景观和基因表达的影响.
- 探索癌症可塑性和治疗耐药性的新型表观遗传-eccDNA轴.
主要方法:
- 使用Circle-seq和RNA测序进行综合分析.
- 采用多omics集成来识别一致的基因变化.
- 应用空间单细胞转录学来分析基因表达模式.
主要成果:
- EZH2抑制显著改变了eccDNA动态和转录程序.
- 鉴定了67个基因,其eccDNA丰富度和转录表达的一致变化.
- 在多个数据集中,SFRP1被Tazemetostat连续地重新激活为瘤抑制剂.
结论:
- 在卵巢癌中,EZH2抑制可能会重新编程eccDNA动态,以恢复SFRP1瘤抑制剂的表达.
- 发现了一种新的表观遗传-eccDNA轴,可能会影响瘤性可塑性和治疗耐药性.
- 这一发现可能会改变针对eccDNA驱动癌症的模式.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
相关概念视频
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
